Publicaciones en colaboración con investigadores/as de Stellenbosch University (63)

2024

  1. The long wait for long-acting HIV prevention and treatment formulations

    The Lancet HIV, Vol. 11, Núm. 10, pp. e711-e716

  2. Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data

    Wellcome Open Research, Vol. 9

2023

  1. A network analysis investigating the associations between posttraumatic stress symptoms, markers of inflammation and metabolic syndrome

    Journal of Psychiatric Research, Vol. 165, pp. 105-114

  2. Brain ageing in schizophrenia: evidence from 26 international cohorts via the ENIGMA Schizophrenia consortium

    Molecular Psychiatry, Vol. 28, Núm. 3, pp. 1201-1209

  3. Effective early antiretroviral therapy in perinatal-HIV infection reduces subsequent plasma inflammatory profile

    Pediatric Research, Vol. 94, Núm. 5, pp. 1667-1674

  4. Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 14

  5. Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial

    The Lancet Child and Adolescent Health, Vol. 7, Núm. 10, pp. 718-727

  6. New living evidence resource of human and non-human studies for early intervention and research prioritisation in anxiety, depression and psychosis

    BMJ mental health, Vol. 26, Núm. 1

  7. Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial

    eClinicalMedicine, Vol. 60

  8. Platelets bridging the gap between gut dysbiosis and neuroinflammation in stress-linked disorders: A narrative review

    Journal of Neuroimmunology, Vol. 382

  9. Trace amine-associated receptor 1 (TAAR1) agonists for psychosis: protocol for a living systematic review and meta-analysis of human and non-human studies.

    Wellcome Open Research, Vol. 8

2022

  1. Advancing the prevention and treatment of HIV in children: priorities for research and development

    The lancet. HIV, Vol. 9, Núm. 9, pp. e658-e666

  2. Associations between telomere length and symptoms of posttraumatic stress disorder and appetitive aggression in trauma-exposed men

    Neuroscience Letters, Vol. 769

  3. Childhood trauma, the stress response and metabolic syndrome: A focus on DNA methylation

    European Journal of Neuroscience, Vol. 55, Núm. 9-10, pp. 2253-2296

  4. Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

    The Lancet HIV, Vol. 9, Núm. 9, pp. e627-e637

  5. Exploring the relationship between the gut microbiome and mental health outcomes in a posttraumatic stress disorder cohort relative to trauma-exposed controls

    European Neuropsychopharmacology, Vol. 56, pp. 24-38

  6. Machine learning outperformed logistic regression classification even with limit sample size: A model to predict pediatric HIV mortality and clinical progression to AIDS

    PloS one, Vol. 17, Núm. 10, pp. e0276116

  7. Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection Times - Children and Adolescents (COH-FIT-C&A)

    Journal of Affective Disorders, Vol. 299, pp. 367-376

  8. The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international online survey targeting physical and mental health effects of the COVID-19 pandemic

    Journal of Affective Disorders, Vol. 299, pp. 393-407

2021

  1. Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children

    New England Journal of Medicine, Vol. 385, Núm. 27, pp. 2531-2543